Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-18-003017
Filing Date
2018-03-16
Accepted
2018-03-16 16:35:51
Documents
24

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1490511
2 filename2.htm EX-3 106579
3 filename3.htm EX-3 127881
4 filename4.htm EX-4 192110
5 filename5.htm EX-10 73848
6 filename6.htm EX-10 62762
7 filename7.htm EX-10 126936
8 filename8.htm EX-21 1588
9 GRAPHIC g428730g19z98.jpg GRAPHIC 86872
10 GRAPHIC g428730g60d82.jpg GRAPHIC 79731
11 GRAPHIC g428730g29z85.jpg GRAPHIC 35923
12 GRAPHIC g428730g74e02.jpg GRAPHIC 27853
13 GRAPHIC g428730g76w85.jpg GRAPHIC 55149
14 GRAPHIC g428730g89b88.jpg GRAPHIC 98614
15 GRAPHIC g428730g70o82.jpg GRAPHIC 146754
16 GRAPHIC g428730g94y79.jpg GRAPHIC 155289
17 GRAPHIC g428730g52y49.jpg GRAPHIC 44256
18 GRAPHIC g428730g86b57.jpg GRAPHIC 38997
19 GRAPHIC g428730g76z10.jpg GRAPHIC 64224
20 GRAPHIC g428730g70e30.jpg GRAPHIC 54968
21 GRAPHIC g428730g95l47.jpg GRAPHIC 67398
22 GRAPHIC g428730g66m31.jpg GRAPHIC 61158
23 GRAPHIC g428730g63w87.jpg GRAPHIC 74061
24 GRAPHIC g428730g14n97.jpg GRAPHIC 39644
  Complete submission text file 0000950123-18-003017.txt   3742896
Mailing Address 300 UTAH AVENUE SUITE 105 SOUTH SAN FRANCISCO CA 94080
Business Address 300 UTAH AVENUE SUITE 105 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01973 | Film No.: 18696086
SIC: 2834 Pharmaceutical Preparations